MX2015012153A - Inhibidores de la quinasa pirrolopirimidina cdk9. - Google Patents
Inhibidores de la quinasa pirrolopirimidina cdk9.Info
- Publication number
- MX2015012153A MX2015012153A MX2015012153A MX2015012153A MX2015012153A MX 2015012153 A MX2015012153 A MX 2015012153A MX 2015012153 A MX2015012153 A MX 2015012153A MX 2015012153 A MX2015012153 A MX 2015012153A MX 2015012153 A MX2015012153 A MX 2015012153A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrrolopyrimindine
- kinase inhibitors
- cdk9 kinase
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se describen compuestos de Fórmula (la), (ver Fórmula) en donde R1, R2 y R3 son como se definen en la descripción, y las sales farmacéuticamente aceptables de los mismos. Los compuestos se pueden usar como agentes en el tratamiento de enfermedades, incluyendo el cáncer. También se proporcionan composiciones farmacéuticas, que comprenden uno o más compuestos de Fórmula (la).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN744DE2013 | 2013-03-14 | ||
PCT/US2014/025670 WO2014160028A1 (en) | 2013-03-14 | 2014-03-13 | Pyrrolopyrimindine cdk9 kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015012153A true MX2015012153A (es) | 2015-12-01 |
Family
ID=54200318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015012153A MX2015012153A (es) | 2013-03-14 | 2014-03-13 | Inhibidores de la quinasa pirrolopirimidina cdk9. |
Country Status (9)
Country | Link |
---|---|
US (1) | US9346813B2 (es) |
EP (1) | EP2970299A1 (es) |
JP (1) | JP2016512560A (es) |
CN (1) | CN105189512A (es) |
AU (1) | AU2014244194A1 (es) |
BR (1) | BR112015023078A2 (es) |
CA (1) | CA2903538A1 (es) |
MX (1) | MX2015012153A (es) |
WO (1) | WO2014160028A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2970299A1 (en) * | 2013-03-14 | 2016-01-20 | Abbvie Inc. | Pyrrolopyrimindine cdk9 kinase inhibitors |
RS58712B1 (sr) | 2015-06-29 | 2019-06-28 | Astrazeneca Ab | Derivati policikličnih amida kao cdk9 inhibitori |
CN112125911B (zh) * | 2020-09-24 | 2022-08-09 | 深圳湾实验室坪山生物医药研发转化中心 | Cdk9抑制剂及其制备方法与应用 |
CN115124537A (zh) * | 2022-07-13 | 2022-09-30 | 山东大学 | 一种jak抑制剂巴瑞替尼的制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
JPH11512429A (ja) | 1995-09-15 | 1999-10-26 | ファルマシア・アンド・アップジョン・カンパニー | アミノアリールオキサゾリジノン n−オキシド |
US20030220234A1 (en) | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
GB9918037D0 (en) | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
GB0115393D0 (en) * | 2001-06-23 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
EP1737850B1 (en) | 2004-04-19 | 2007-10-03 | Symed Labs Limited | A novel process for the preparation of linezolid and related compounds |
ES2325401T3 (es) | 2004-07-20 | 2009-09-03 | Symed Labs Limited | Intermedios novedosos para linezolid y compuestos relacionados. |
TW200615268A (en) * | 2004-08-02 | 2006-05-16 | Osi Pharm Inc | Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
CN101052629A (zh) * | 2004-08-02 | 2007-10-10 | Osi制药公司 | 芳基-氨基取代的吡咯并嘧啶多激酶抑制化合物 |
EP1804823A4 (en) | 2004-09-29 | 2010-06-09 | Amr Technology Inc | NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS |
TW200716636A (en) | 2005-05-31 | 2007-05-01 | Speedel Experimenta Ag | Heterocyclic spiro-compounds |
US7514068B2 (en) | 2005-09-14 | 2009-04-07 | Concert Pharmaceuticals Inc. | Biphenyl-pyrazolecarboxamide compounds |
US8796267B2 (en) | 2006-10-23 | 2014-08-05 | Concert Pharmaceuticals, Inc. | Oxazolidinone derivatives and methods of use |
WO2008049856A2 (en) | 2006-10-25 | 2008-05-02 | Ingenium Pharmaceuticals Gmbh | Methods of treating pain using cdk inhibitors |
WO2008079918A1 (en) | 2006-12-22 | 2008-07-03 | Novartis Ag | Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
MX2009008465A (es) | 2007-02-15 | 2009-08-20 | Hoffmann La Roche | Nuevas 2-aminooxazolinas como ligandos de taar1. |
EP2139869A2 (en) * | 2007-04-13 | 2010-01-06 | SuperGen, Inc. | Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
BRPI0810362A2 (pt) | 2007-04-19 | 2014-10-29 | Concert Pharmaceuticals Inc | Compostos de morfolinila deuterados |
US7531685B2 (en) | 2007-06-01 | 2009-05-12 | Protia, Llc | Deuterium-enriched oxybutynin |
GB0710528D0 (en) | 2007-06-01 | 2007-07-11 | Glaxo Group Ltd | Novel compounds |
US20090131485A1 (en) | 2007-09-10 | 2009-05-21 | Concert Pharmaceuticals, Inc. | Deuterated pirfenidone |
US20090118238A1 (en) | 2007-09-17 | 2009-05-07 | Protia, Llc | Deuterium-enriched alendronate |
US20090082471A1 (en) | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched fingolimod |
US20090088416A1 (en) | 2007-09-26 | 2009-04-02 | Protia, Llc | Deuterium-enriched lapaquistat |
WO2009045476A1 (en) | 2007-10-02 | 2009-04-09 | Concert Pharmaceuticals, Inc. | Pyrimidinedione derivatives |
EP2212297B1 (en) | 2007-10-12 | 2011-05-25 | Ingenium Pharmaceuticals GmbH | Inhibitors of protein kinases |
US20090105338A1 (en) | 2007-10-18 | 2009-04-23 | Protia, Llc | Deuterium-enriched gabexate mesylate |
US8410124B2 (en) | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
AU2008317375B2 (en) | 2007-10-26 | 2013-02-28 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
WO2010003133A2 (en) | 2008-07-03 | 2010-01-07 | Exelixis Inc. | Cdk modulators |
BRPI0917791B1 (pt) | 2008-08-22 | 2022-03-22 | Novartis Ag | Compostos de pirrolopirimidina como inibidores de cdk, bem como composição farmacêutica e combinação |
WO2013157021A1 (en) | 2012-04-20 | 2013-10-24 | Advinus Therapeutics Limited | Bicyclic compounds, compositions and medicinal applications thereof |
EP2970299A1 (en) * | 2013-03-14 | 2016-01-20 | Abbvie Inc. | Pyrrolopyrimindine cdk9 kinase inhibitors |
-
2014
- 2014-03-13 EP EP14717323.1A patent/EP2970299A1/en not_active Withdrawn
- 2014-03-13 JP JP2016501937A patent/JP2016512560A/ja active Pending
- 2014-03-13 AU AU2014244194A patent/AU2014244194A1/en not_active Abandoned
- 2014-03-13 WO PCT/US2014/025670 patent/WO2014160028A1/en active Application Filing
- 2014-03-13 CA CA2903538A patent/CA2903538A1/en not_active Abandoned
- 2014-03-13 CN CN201480027764.8A patent/CN105189512A/zh active Pending
- 2014-03-13 MX MX2015012153A patent/MX2015012153A/es unknown
- 2014-03-13 US US14/207,868 patent/US9346813B2/en active Active
- 2014-03-13 BR BR112015023078A patent/BR112015023078A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN105189512A (zh) | 2015-12-23 |
BR112015023078A2 (pt) | 2017-07-18 |
EP2970299A1 (en) | 2016-01-20 |
US9346813B2 (en) | 2016-05-24 |
WO2014160028A1 (en) | 2014-10-02 |
CA2903538A1 (en) | 2014-10-02 |
US20140275004A1 (en) | 2014-09-18 |
AU2014244194A1 (en) | 2015-09-10 |
JP2016512560A (ja) | 2016-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015012432A (es) | Inhibidores piridinicos de la cinasa cdk9. | |
PH12016500024A1 (en) | Bromodomain inhibitor | |
MX2015011984A (es) | Inhibidores de bromodominio de dihidro-pirrolopiridinona. | |
MD20170016A2 (ro) | Compuşi aminopirimidinici ca inhibitori JAK | |
PH12015502004A1 (en) | Tetracyclic bromodomain inhibitors | |
MX2015012431A (es) | Pirrol amida como inhibidores. | |
MX2015012005A (es) | Inhibidores de bromodominio. | |
MX2016007346A (es) | Derivados de dihidropiridinona y dihidropiridazinona utiles como inhibidores de bromodominio. | |
SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
IN2015DN01156A (es) | ||
MY192521A (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors | |
MX2014012695A (es) | Derivados de isoindolona. | |
PH12016500170A1 (en) | Formulation of syk inhibitors | |
MX2015012158A (es) | Inhibidores de bomodominio tetraciclicos fusionados. | |
MX2016006432A (es) | Tetrahidro-benzodiazepinonas. | |
MX344335B (es) | Derivados de benzonitrilo como inhibidores de cinasa. | |
PH12014501542B1 (en) | Substituted pyrrolidine -2- carboxamides | |
PH12015502159A1 (en) | Chemical entities | |
MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
MX2015010829A (es) | Compuestos terapeuticos y sus usos. | |
PH12016502353A1 (en) | Pharmaceutical composition | |
MX2015016425A (es) | Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades. | |
MX2018004664A (es) | Antagonistas de ep4. | |
MX2016007440A (es) | Inhibidores del bromodominio. | |
MX2015012896A (es) | Inhibidores de pirrolo [2,3-b] piridina cdk9 cinasa. |